(Q74325241)

English

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

scientific article published on 01 February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

B Mackness

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M I Mackness

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Arrol

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W Turkie

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P N Durrington

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

423

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

57-60

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

HDL, its enzymes and its potential to influence lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Presence of paraoxonase in human interstitial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900064-7

7 January 2021

Identifiers

10.1016/S0014-5793(98)00064-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9506841%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74325241&oldid=1933581383"